13F-HR/A filed by Eversept Partners, LP
Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2020-12-31, filed 2023-11-08, with 60 holding rows worth $851,932,472.
- Accession
- 0001697013-23-000019
- Filer
- CIK 1697013
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, amendment of type restatement, 60 entries on the cover page, a total value of $851,932,472 stated on the cover page (in dollars after the unit check, H1), rows summing to $851,932,472 with VALUE read as dollars as filed, 13F file number 028-18369. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 15,943,915 | $77,965,744 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 458,636 | $69,616,358 | dollars as filed | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 376,200 | $58,777,488 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 863,851 | $44,937,529 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 852,431 | $42,613,026 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 530,976 | $38,840,894 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 399,499 | $36,326,444 | dollars as filed | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 946,581 | $35,196,522 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 187,043 | $31,195,032 | dollars as filed | |
| CATALENT INC USD 0.01 | 148806102 | COM | 279,503 | $29,087,877 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 861,355 | $29,053,504 | dollars as filed | |
| Danaher Corporation | 235851102 | COM | 126,330 | $28,082,373 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,748,250 | $26,520,613 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 920,650 | $25,916,298 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 138,644 | $23,637,416 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 65,771 | $21,118,410 | dollars as filed | |
| ZOGENIX INC. | 98978L204 | Common Stock | 909,708 | $18,185,063 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 336,862 | $17,803,157 | dollars as filed | |
| ENSIGN GROUP INC | 29358P101 | COM | 208,470 | $15,213,890 | dollars as filed | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 246,240 | $14,052,917 | dollars as filed | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 352,600 | $12,975,680 | dollars as filed | call |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 356,235 | $11,328,273 | dollars as filed | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 152,256 | $11,178,636 | dollars as filed | |
| HESKA CORP | 42805E306 | COM | 76,166 | $11,093,578 | dollars as filed | |
| KADMON HLDGS INC | 48283N106 | COM | 2,408,885 | $9,996,873 | dollars as filed | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 103,764 | $8,893,612 | dollars as filed | |
| MAGELLAN HEALTH SERVICES INC | 559079207 | COM NEW | 104,700 | $8,673,348 | dollars as filed | |
| RITE AID CORP | 767754872 | COM | 532,004 | $8,421,623 | dollars as filed | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 604,368 | $8,358,409 | dollars as filed | |
| SERES THERAPEUTICS INC | 81750R102 | COM | 334,049 | $8,184,201 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 40,583 | $7,290,736 | dollars as filed | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,285,400 | $6,285,606 | dollars as filed | call |
| AFFIMED N V | N01045108 | COM | 964,707 | $5,614,595 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 1,178,153 | $5,384,159 | dollars as filed | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 307,742 | $5,374,714 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 380,000 | $4,286,400 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 491,852 | $3,664,297 | dollars as filed | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 209,155 | $3,557,727 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 68,138 | $3,310,825 | dollars as filed | |
| HCA Healthcare Inc | 40412C101 | COM | 16,754 | $2,755,363 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 203,328 | $2,441,969 | dollars as filed | |
| SESEN BIO INC | 817763105 | COM | 1,559,824 | $2,105,762 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 88,334 | $1,899,181 | dollars as filed | |
| Surmodics Inc | 868873100 | Common Stock | 41,299 | $1,797,332 | dollars as filed | |
| ONCTERNAL THERAPEUTICS INC | 68236P107 | COM | 344,090 | $1,686,041 | dollars as filed | |
| OTONOMY INC | 68906L105 | COM | 253,283 | $1,638,741 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 154,981 | $1,385,530 | dollars as filed | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 103,829 | $1,312,399 | dollars as filed | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 522,042 | $1,117,170 | dollars as filed | |
| EXAGEN INC | 30068X103 | COM | 81,603 | $1,077,160 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 2,473 | $914,318 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 36,310 | $879,065 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 4,085 | $731,909 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 4,977 | $589,725 | dollars as filed | |
| GOHEALTH INC | 38046W105 | COM CL A | 29,685 | $405,497 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 18,925 | $359,386 | dollars as filed | |
| ZYMEWORKS INC | 98985W102 | COM | 5,405 | $255,440 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 14,445 | $253,221 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,816 | $218,275 | dollars as filed | |
| COMMUNITY HEALTH SYSTEMS INC | 203668108 | COMMON STOCK | 12,805 | $95,141 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001697013-21-000002 | superseded | 2021-02-16 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000019 | this filing | 2023-11-08 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001697013-23-000020 | added | 2023-11-08 | acceptance time not in the bulk data set |